US could reclassify marijuana today. Will it be legal in Florida?

The US may reclassify marijuana as a less dangerous drug this week. Here's what that means for Florida's cannabis users.

The Trump administration may reclassify marijuana. Here's what that means

In December, U.S. President Donald Trump signed an executive order to ease federal restrictions on marijuana, setting the ...

Trump’s Justice Department Could Reclassify Marijuana As A Safer Drug Wednesday

President Trump previously directed the Justice Department to reschedule the drug in a December executive order.

Donald Trump Could Reclassify Marijuana This Week: Details

The pot industry could incur a big change this week… The post Donald Trump Could Reclassify Marijuana This Week: Details ...
Drinks

Trump signs order to reclassify marijuana

Donald Trump signs an executive order in the Oval Office on 18 December 2025 directing his administration to move cannabis into a less restrictive federal category, setting in motion a regulatory ...
Morningstar

After Trump's move to reclassify cannabis, here's what Wall Street is thinking

Analysts are now focused on the when the change will actually happen, as the cannabis industry waits for tax relief and expanded research opportunities President Donald Trump signs an executive order ...
New Orleans City Business

Trump signs executive order that could reclassify marijuana as a less dangerous drug

President Donald Trump signed an executive order Thursday that could reclassify marijuana as a less dangerous drug and open new avenues for medical research, a major shift in federal drug policy ...
KVOA 4

Trump signs executive order to reclassify marijuana, ease federal restrictions

TUCSON, Ariz. (KVOA) - A big change is now in the works for marijuana at the federal level. President Donald Trump signed an executive order, Thursday, to expedite the process to reclassify ...
Devdiscourse

U.S. to Reclassify Marijuana, Marking Major Policy Shift

The United States administration is set to reclassify marijuana, marking a significant federal policy shift. This move is aimed at removing barriers to research the drug's use cases, following an ...